Hosted by Florida Society of Clinical Oncology · 🇺🇸 US · EN · 26 episodes
Established thought leaders with verified media credentials.
The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected. It’s your go-to source for staying up-to-date on FLASCO’s efforts to support and strengthen the oncology community across Florida.
Florida Society of Clinical Oncology hosts FLASCO OncoPod, a health show with 26 episodes published.
The treatment landscape for chronic lymphocytic leukemia (CLL) has transformed dramatically over the past decade, creating new opportunities and new questions for clinicians managing this increasingly complex disease. In
Join Scott E. Jordan, MD, FACOG, gynecologic oncologist at Broward Health, as he breaks down the most important endometrial cancer updates presented at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting. In th
What does it take to successfully navigate the business of oncology while continuing to deliver exceptional patient care? In this episode of the FLASCO OncoPod, Dr. Robin Zon joins Dr. Jorge Garcia for a thoughtful conve
In this final episode of the FLASCO OncoPod series, Drs. Jaglal, Fu, and Shahzad shift focus to the long-term management of atypical hemolytic uremic syndrome (aHUS) in oncology patients. Building on the diagnostic and a
In this episode of the FLASCO OncoPod, Drs. Jaglal, Fu, and Shahzad explore the real-world challenges of managing suspected thrombotic microangiopathy (TMA) in oncology patients. Building on a complex multiple myeloma ca
Atypical hemolytic uremic syndrome (aHUS) in patients with malignancy or undergoing cancer-directed therapy is likely under-recognized, yet early identification can have a profound impact on patient outcomes. In this FLA
Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Noman Ashraf, MD, of Tampa General Hospital Cancer Institute for the final installment of the Adva
Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Noman Ashraf of Tampa General Hospital Cancer Institute and Dr. Umair Majeed of Mayo Clinic in Jac
Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Paresh Patel and Dr. Masoumeh Ghayouri for the second installment of the Advancing Care in GI and
Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals and GI Oncologist Dr. Umair Majeed of Mayo Clinic in Jacksonville for the first installment of the Advancing Care
Join Dr. Edgardo Santos and Dr. Luis Raez for a practical discussion on first-line decision-making in EGFR-mutated lung cancer and how early treatment choices shape survival, sequencing, and patient experience. This epis
Join Dr. Paresh Patel and Dr. Masoumeh Ghayouri for a crucial conversation on the complexities of HER2 testing in Gastrointestinal (GI) cancers, including Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (B
Join Dr. Paresh Patel and Dr. Masoumeh Ghayouri for a crucial conversation on the complexities of HER2 testing in Gastrointestinal (GI) cancers, including Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (B
Join moderator Dr. Tiago Bianchi and an expert multidisciplinary panel, including Zilipah Cruz, MSN-RN, ONN-CG, Vanessa Sepulveda-Dominguez, RN, BSN, and Charlotte Martin, PharmD, for a deep dive into the essential non-c
The mCRC Journey: Treatment Sequencing and Real-World Decisions (Epi. 2) Join medical oncologists Dr. Tiago Bianchi and Dr. Raji Shameem for Episode 2 of our "Voices in Colorectal Cancer" Series as they navigate the comp
In this first episode of the "Voices in Colorectal Cancer" Series, medical oncologists Dr. Tiago Bianchi and Dr. Raji Shameem confront the dramatic shift in colorectal cancer (CRC) presentation, drawing on urgent, real-w
In this new OncoPod episode, Dr. Christopher R. Cogle (University of Florida) and Dr. Neil M. Iyengar (Winship Cancer Institute at Emory University) discuss an often-overlooked gap in oncology care - the absence of a str
In this episode, FLASCO leaders Maen Hussein, MD, and Wassim McHayleh, MD join the discussion to explore the evolving role of ESR1 mutation testing in metastatic breast cancer. They highlight how these mutations, both ac
In this episode, Dr. Ariel Perez Perez and Dr. Jose Sandoval-Sus, two of the coauthors of the FLASCO Consensus on Operationalizing Bispecifics for Lymphoma in the Community Setting discuss the core findings and practical
In this episode, Dr. Michael Jaglal, Dr. Maen Hussein, and Dr. Jorge Garcia come together to discuss paroxysmal nocturnal hemoglobinuria (PNH), a rare but serious hematologic condition. From clinical presentation and dia
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch FLASCO OncoPod, visit https://flasco.org/oncology-professionals/podcasts/ for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent health coverage.
FLASCO OncoPod is hosted by Florida Society of Clinical Oncology. The show is categorised under health (fitness) and has published 26 episodes.
FLASCO OncoPod has published 26 episodes.
FLASCO OncoPod regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
FLASCO OncoPod is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
FLASCO OncoPod hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of FLASCO OncoPod average 19 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates FLASCO OncoPod's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 6 days ago.
